News & Perspective

Sep 22, 2017

Sep 22, 2017

ASP Scan (Weekly) for Sep 22, 2017

One Health stewardship
MRSA risk in the home
Resistant farm E coli in China
MDR malaria spread
Pediatric antimicrobial stewardship
New US Candida auris cases
Post-cesarean antibiotics
Point-of-care testing
Pneumonia vaccine and antibiotics
New vaginosis antibiotic
Gene sequencing for CRE
C diff and tetracyclines
Resistant E coli clone in kids
New pneumonia antibiotic
UK strep guidelines

Dec 12, 2016

Dec 12, 2016

Flu Scan for Dec 12, 2016

H7N9 cases in China
Avian flu in France, Finland
Generic Tamiflu

Jun 13, 2016

Jun 13, 2016

News Scan for Jun 13, 2016

Flour confirmed as E coli source
MCR-1 in Japan and Colombia
Chikungunya tops 2M cases

Dec 22, 2014

Dec 22, 2014
Package of Rapivab (peramivir), a flu drug

FDA approval of peramivir makes IV flu drug available

Peramivir, made by BioCryst, is intended to be given to influenza patients in a single intravenous dose.

Apr 08, 2013

Apr 08, 2013

CDC waiting for H7N9 sample to speed test kits

(CIDRAP News) – A human isolate of the novel H7N9 influenza virus from China—needed for the development of diagnostic test kits and related efforts—is expected to arrive at the Centers for Disease Control and Prevention (CDC) within 2 days, a CDC official said today.

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»